Verition Fund Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Verition Fund Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100,000	Closed	-$310K	–	3284
2021 Q4	$310K	Buy	+100,000	New	+$337K	﹤0.01%	1971
2019 Q2	–	Sell	-37,965	Closed	-$201K	–	1544
2019 Q1	$201K	Buy	+37,965	New	+$173K	0.01%	969
2015 Q4	–	Sell	-59,000	Closed	-$328K	–	704
2015 Q3	$328K	Sell	59,000 -50,805	-46%	-$375K	0.09%	315
2015 Q2	$874K	Sell	109,805 -41,221	-27%	-$354K	0.15%	106
2015 Q1	$1.59M	Buy	+151,026	New	+$2.06M	0.18%	34

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Verition Fund Management's BDSI Position: Q1 2022 in Review

Verition Fund Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 100,000 shares — an estimated $310K sold.

Verition Fund Management first reported a position in BDSI in Q1 2015 and held it in 5 quarters. The position peaked at $1.59M in Q1 2015. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Verition Fund Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Verition Fund Management sold 100,000 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $310K.
Verition Fund Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 5 quarters.
Verition Fund Management's BioDelivery Sciences International, Inc. position peaked at $1.59M in Q1 2015.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Verition Fund Management's 13F filing for Q1 2022, filed 13 May 2022.